Evidence map›Paper›PMID 30085063›Full record

ReviewFEMS microbiology reviews2018

Strategies to combat antimicrobial resistance: anti-plasmid and plasmid curing.

Michelle M C Buckner, Maria Laura Ciusa, Laura J V Piddock

Abstract readReview
In one paragraph

Review in FEMS microbiology reviews, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed.

  1. Characterization of defensome genes and mobile genetic Elements in different types of pasture soil agroecosystems from the Brazilian Amazon.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  2. Sensitizing carbapenem-resistant Klebsiella pneumoniae using a compact Cascade-Cas3 system.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Plasmid Curing ofBio-protocol · 2026
    Article
  9. Article
  10. Article
  11. Molecular Insights into Carbapenem Resistance inInternational journal of molecular sciences · 2026
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Avian PathogenicVeterinary sciences · 2025
    Review
  18. Article
  19. Article
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Michelle M C BucknerInstitute of Microbiology and Infection, College of Medical and Dental Sciences, The University of Birmingham B15 2TT, UK.
Maria Laura CiusaInstitute of Microbiology and Infection, College of Medical and Dental Sciences, The University of Birmingham B15 2TT, UK.
Laura J V PiddockInstitute of Microbiology and Infection, College of Medical and Dental Sciences, The University of Birmingham B15 2TT, UK.

Funding

Medical Research Council MR/N012933/1
6 · The paper itself

Abstract

Antimicrobial resistance (AMR) is a global problem hindering treatment of bacterial infections, rendering many aspects of modern medicine less effective. AMR genes (ARGs) are frequently located on plasmids, which are self-replicating elements of DNA. They are often transmissible between bacteria, and some have spread globally. Novel strategies to combat AMR are needed, and plasmid curing and anti-plasmid approaches could reduce ARG prevalence, and sensitise bacteria to antibiotics. We discuss the use of curing agents as laboratory tools including chemicals (e.g. detergents and intercalating agents), drugs used in medicine including ascorbic acid, psychotropic drugs (e.g. chlorpromazine), antibiotics (e.g. aminocoumarins, quinolones and rifampicin) and plant-derived compounds. Novel strategies are examined; these include conjugation inhibitors (e.g. TraE inhibitors, linoleic, oleic, 2-hexadecynoic and tanzawaic acids), systems designed around plasmid incompatibility, phages and CRISPR/Cas-based approaches. Currently, there is a general lack of in vivo curing options. This review highlights this important shortfall, which if filled could provide a promising mechanism to reduce ARG prevalence in humans and animals. Plasmid curing mechanisms which are not suitable for in vivo use could still prove important for reducing the global burden of AMR, as high levels of ARGs exist in the environment.

Indexed as

AnimalsAnti-Bacterial AgentsBacteriaDrug Resistance, BacterialEnvironmental MicrobiologyGenes, BacterialGene Transfer, HorizontalHumansPlasmidsAnti-Bacterial Agents

Identifiers

PMID30085063
PMCPMC6199537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.